Literature DB >> 16051738

The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis.

Richard van Wijk1, Wouter W van Solinge.   

Abstract

The red blood cell depends solely on the anaerobic conversion of glucose by the Embden-Meyerhof pathway for the generation and storage of high-energy phosphates, which is necessary for the maintenance of a number of vital functions. Many red blood cell enzymopathies have been described that disturb the erythrocyte's integrity, shorten its cellular survival, and result in hemolytic anemia. By far the majority of these enzymopathies are hereditary in nature. In this review, we summarize the current knowledge regarding the genetic, biochemical, and structural features of clinically relevant red blood cell enzymopathies involved in the Embden-Meyerhof pathway and the Rapoport-Luebering shunt.

Entities:  

Mesh:

Year:  2005        PMID: 16051738     DOI: 10.1182/blood-2005-04-1622

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  78 in total

1.  Depletion of hemoglobin and carbonic anhydrase from erythrocyte cytosolic samples by preparative clear native electrophoresis.

Authors:  Gian Maria D'Amici; Sara Rinalducci; Lello Zolla
Journal:  Nat Protoc       Date:  2011-12-08       Impact factor: 13.491

Review 2.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 3.  The implications of human metabolic network topology for disease comorbidity.

Authors:  D-S Lee; J Park; K A Kay; N A Christakis; Z N Oltvai; A-L Barabási
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-03       Impact factor: 11.205

Review 4.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

5.  Mitochondrial localization and moderated activity are key to murine erythroid enucleation.

Authors:  Raymond Liang; Vijay Menon; Jiajing Qiu; Tasleem Arif; Santosh Renuse; Miao Lin; Roberta Nowak; Boris Hartmann; Nikos Tzavaras; Deanna L Benson; Jerry E Chipuk; Miguel Fribourg; Akhilesh Pandey; Velia Fowler; Saghi Ghaffari
Journal:  Blood Adv       Date:  2021-05-25

6.  Function and dysfunction.

Authors:  Narla Mohandas
Journal:  Blood       Date:  2018-05-17       Impact factor: 22.113

7.  Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.

Authors:  Pei-Hsuan Chen; Ling Cai; Kenneth Huffman; Chendong Yang; Jiyeon Kim; Brandon Faubert; Lindsey Boroughs; Bookyung Ko; Jessica Sudderth; Elizabeth A McMillan; Luc Girard; Dong Chen; Michael Peyton; Misty D Shields; Bo Yao; David S Shames; Hyun Seok Kim; Brenda Timmons; Ikuo Sekine; Rebecca Britt; Stephanie Weber; Lauren A Byers; John V Heymach; Jing Chen; Michael A White; John D Minna; Guanghua Xiao; Ralph J DeBerardinis
Journal:  Mol Cell       Date:  2019-09-26       Impact factor: 17.970

Review 8.  Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasis.

Authors:  Yasuyuki Goto; Jingjie Cheng; Satoko Omachi; Ayako Morimoto
Journal:  Parasitol Res       Date:  2016-11-07       Impact factor: 2.289

9.  Individual variability in human blood metabolites identifies age-related differences.

Authors:  Romanas Chaleckis; Itsuo Murakami; Junko Takada; Hiroshi Kondoh; Mitsuhiro Yanagida
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

10.  Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Authors:  Amélie Bonnefond; Martine Vaxillaire; Yann Labrune; Cécile Lecoeur; Jean-Claude Chèvre; Nabila Bouatia-Naji; Stéphane Cauchi; Beverley Balkau; Michel Marre; Jean Tichet; Jean-Pierre Riveline; Samy Hadjadj; Yves Gallois; Sébastien Czernichow; Serge Hercberg; Marika Kaakinen; Susanne Wiesner; Guillaume Charpentier; Claire Lévy-Marchal; Paul Elliott; Marjo-Riitta Jarvelin; Fritz Horber; Christian Dina; Oluf Pedersen; Robert Sladek; David Meyre; Philippe Froguel
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.